Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The familial form of infantile bilateral striatal necrosis (IBSN), a syndrome of bilateral symmetric spongy degeneration of the caudate nucleus, putamen and globus pallidus characterized by developmental regression, choreoathetosis and dystonia progressing to spastic quadriparesis.
Features include common findings: Difficulty swallowing (dysphagia), Choreoathetosis, Loss of previously acquired skills (developmental regression), and Dystonia and others; and sometimes findings: Hypertonia, Sudden, brief involuntary muscle jerks (myoclonus), Gastroesophageal reflux, and Muscle stiffness (rigidity) and others. 39 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 19 |
NUP62 encodes nucleoporin 62 (522 aa). Essential component of the nuclear pore complex. The N-terminal is probably involved in nucleocytoplasmic transport. Highest expression in Cells EBV-transformed lymphocytes (93.4 TPM) and Testis (64.2 TPM).
Familial infantile bilateral striatal necrosis is associated with mutations in the NUP62 gene on chromosome 19.
The NUP62 protein participates in HSP90:ATP:p23:FKBP52:SHR:SH translocates to the nucleus pathway.
NUP62 is classified as a druggable target (Druggable Genome and Transporter categories) with score 1.9.
Genetic testing for NUP62 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 23 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for familial infantile bilateral striatal necrosis.
1 publication has been identified in PubMed for familial infantile bilateral striatal necrosis. Research spans Review / Meta-Analysis (100%).
Fare CM (2024). [PMID: 38383349](https://pubmed.ncbi.nlm.nih.gov/38383349/). *Nucleus*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 10:39 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles | 6 | Damage to the optic nerve (optic atrophy), Atrophy/Degeneration involving the caudate nucleus, Frequent falls |
Eyes | 3 | Pendular nystagmus, Damage to the optic nerve (optic atrophy), Horizontal pendular nystagmus |
Digestive system | 2 | Difficulty swallowing (dysphagia), Gastroesophageal reflux |
Arms and legs | 2 | Upper limb muscle weakness, Lower limb muscle weakness |
Growth and development | 1 | Failure to thrive |
Age of onset: childhood.